Aura Biosciences Inc.

NASDAQ: AURA · Real-Time Price · USD
6.73
-0.27 (-3.86%)
At close: Aug 15, 2025, 3:59 PM
6.85
1.78%
After-hours: Aug 15, 2025, 05:02 PM EDT

Aura Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
1.22M 1.29M 1.18M 835K
Gross Profit
n/a -1.29M -1.18M -835K
Operating Income
-96.12M -84.99M -60.3M -35.25M
Interest Income
n/a n/a 1.86M 13K
Pretax Income
-86.81M -76.27M -58.76M -35.25M
Net Income
-86.92M -76.41M -57.23M -34.42M
Selling & General & Admin
22.81M 19.76M 18.06M 10.09M
Research & Development
73.3M 63.94M 42.24M 25.16M
Other Expenses
n/a n/a -5K -11K
Operating Expenses
96.12M 84.99M 60.3M 35.25M
Interest Expense
n/a n/a n/a 13K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
-96.12M 84.99M 60.3M 35.25M
Income Tax Expense
112K 137K -1.53M -830K
Shares Outstanding (Basic)
49.65M 39.62M 29.94M 29.21M
Shares Outstanding (Diluted)
49.65M 39.62M 29.94M 29.21M
EPS (Basic)
-1.75 -1.93 -1.91 -1.18
EPS (Diluted)
-1.75 -1.93 -1.91 -1.18
EBITDA
-85.58M -83.7M -59.12M -34.42M
EBIT
-86.81M -84.99M -60.3M -35.25M
Depreciation & Amortization
1.22M 1.29M 1.18M 835K